Opsor (Salicylic Acid)

Salicylic acid is a beta‑hydroxy acid that penetrates the outer skin layer, loosening the bonds between dead skin cells. This promotes desquamation and reduces hyperkeratosis. Additionally, it has mild anti‑inflammatory properties that help calm redness and swelling associated with acne and other skin lesions.

The specific amount and frequency of Opsor application are determined by the prescribing clinician based on the patient’s condition, skin type and treatment area. Patients should follow the healthcare provider’s instructions and not exceed the recommended amount.

Opsor should be used during pregnancy or lactation only if the prescribing healthcare professional deems it necessary. While topical salicylic acid is generally low‑systemic, caution is advised, especially for extensive application, and a risk‑benefit assessment should be performed.

To request Opsor, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Opsor’s salicylic acid formulation offers a well‑established balance of exfoliation and anti‑inflammatory action. Compared with alternatives such as glycolic acid or urea, salicylic acid provides deeper penetration into oily skin and is particularly effective for comedonal acne, while generally causing less stinging than higher‑strength alpha‑hydroxy acids.

Opsor should be stored at ambient temperature, ideally below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Opsor is a topical preparation applied to clean, dry skin. A thin layer is spread over the affected area, avoiding healthy skin, open wounds or mucous membranes. The product is typically left on for the period advised by the prescriber before being washed off or left in place, depending on the formulation.

Serious risks, though rare, include allergic contact dermatitis, systemic salicylate toxicity when large skin areas are treated, and severe ulceration or deep skin breakdown. Patients should monitor for intense itching, swelling, blistering or systemic symptoms such as tinnitus and seek medical attention promptly if they occur.

Opsor should not be used by individuals with known hypersensitivity to salicylic acid or any excipients in the formulation, on broken or infected skin, or on children under 12 years old unless specifically directed by a physician. Patients on systemic salicylates should also use it only under medical supervision.